대사 어세이 시장 : 제품 유형, 용도, 기술, 최종 용도별 - 세계 예측(2024-2032년)

The metabolism assays market is predicted to observe 7.6% CAGR between 2024 and 2032. The surge in metabolic disorders such as diabetes, obesity, and cardiovascular diseases is amplifying the need for comprehensive metabolic research. As per the CDC, 38.4 million people had diabetes as of 2021 which is nearly 11.6% of the U.S. population.

Technological advancements, particularly in high-throughput screening and automated systems, are enabling researchers to conduct more efficient and large-scale metabolism assays. Furthermore, the rise of personalized medicine is creating a demand for tailored solutions, driving innovation in the metabolism assays market to meet the unique requirements of individual patients.

The overall metabolism assays industry is classified based on product type, application, technology, end-use, and region.

The instruments and analyzers segment is anticipated to witness 7.3% CAGR between 2024 and 2032 owing to the precise and high-throughput metabolic research. Cutting-edge instruments and analyzers are essential for accurate measurements of cellular metabolism, enabling researchers to gain insights into metabolic pathways and identify potential therapeutic targets. This segment is witnessing rapid advancements, with state-of-the-art technologies enhancing the efficiency and reliability of metabolic assays.

The diagnostics application segment is expected to record 7.9% CAGR during 2024 and 2032 as metabolic profiling becomes integral in clinical settings. Metabolism assays are playing a crucial role in diagnostics, offering valuable information for disease diagnosis, prognosis, and monitoring treatment responses. The increasing adoption of metabolic profiling in clinical laboratories provide clinicians with valuable tools to make informed decisions and personalize patient care.

Europe metabolism assays market will observe 7.1% CAGR during 2024 and 2032 owing to a robust infrastructure supporting advanced R&D activities. The region boasts a high concentration of leading research institutions and pharmaceutical companies actively engaged in metabolic studies. Furthermore, favorable government initiatives and funding for life sciences research contribute to the flourishing market in Europe.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & working
  • 1.2.1 Data collection
• 1.3 Forecast parameters
• 1.4 Data validation
• 1.5 Data sources
  • 1.5.1 Primary
  • 1.5.2 Secondary
    • 1.5.2.1 Paid sources
    • 1.5.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Metabolism assays industry 360 degree synopsis, 2018 - 2032
• 2.2 Business trends
• 2.3 Regional trends
• 2.4 Product type trends
• 2.5 Application trends
• 2.6 Technology trend
• 2.7 End-use trends

Chapter 3 Metabolism Assays Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rise in prevalence of chronic diseases
    • 3.2.1.2 Increasing R&D expenditure
    • 3.2.1.3 Technological advancements
    • 3.2.1.4 Growing demand for personalized medicines
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of metabolism assay analyzers
    • 3.2.2.2 Presence of alternative methods and techniques
• 3.3 Growth potential analysis
  • 3.3.1 By product type
  • 3.3.2 By application
  • 3.3.3 By technology
  • 3.3.4 By end-use
• 3.4 Regulatory landscape
• 3.5 Reimbursement scenario
• 3.6 Technology landscape
• 3.7 Future market trends
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis, 2023
• 4.3 Company market share analysis, 2023
• 4.4 Competitive positioning matrix
• 4.5 Vendor matrix analysis
• 4.6 Strategy dashboard, 2023

Chapter 5 Metabolism Assays Market Size and Forecast, By Product Type, 2018-2032 (USD Million)

• 5.1 Key product type trends
• 5.2 Assay kits & reagents
• 5.3 Instruments & analyzers

Chapter 6 Metabolism Assays Market Size and Forecast, By Application, 2018-2032 (USD Million)

• 6.1 Key application trends
• 6.2 Diagnostics
  • 6.2.1 Diabetes
  • 6.2.2 Obesity
  • 6.2.3 Cancer
  • 6.2.4 Cardiovascular diseases
  • 6.2.5 Other diagnostic applications
• 6.3 Research

Chapter 7 Metabolism Assays Market Size and Forecast, By Technology, 2018-2032 (USD Million)

• 7.1 Key technology trends
• 7.2 Colorimetry
• 7.3 Fluorimetry
• 7.4 Spectrometry

Chapter 8 Metabolism Assays Market Size and Forecast, By End-use, 2018-2032 (USD Million)

• 8.1 Key end-use trends
• 8.2 Hospitals
• 8.3 Diagnostic laboratories
• 8.4 Pharmaceutical & biopharmaceutical companies
• 8.5 Other end-users

Chapter 9 Metabolism Assays Market Size and Forecast, By Region, 2018-2032 (USD Million)

• 9.1 Key regional trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East & Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of MEA

Chapter 10 Company Profiles

• 10.1 Merck KGaA
• 10.2 Thermo Fisher Scientific, Inc.
• 10.3 Abcam Plc
• 10.4 Agilent Technologies, Inc.
• 10.5 Promega Corporation
• 10.6 Kaneka Eurogentec S.A (Kaneka Corporation)
• 10.7 RayBiotech Life, Inc.
• 10.8 Sartorius AG
• 10.9 Elab Science Biotechnology Inc.
• 10.10 BMG Labtech
• 10.11 Biotrend Chemikalien GmbH